158 related articles for article (PubMed ID: 37944339)
1. Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022.
Syrjanen R; Greene SL; Weber C; Smith JL; Hodgson SE; Abouchedid R; Gerostamoulos D; Maplesden J; Knott J; Hollerer H; Rotella JA; Graudins A; Schumann JL;
Int J Drug Policy; 2023 Dec; 122():104245. PubMed ID: 37944339
[TBL] [Abstract][Full Text] [Related]
2. A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia - Victoria (EDNAV) project.
Syrjanen R; Schumann JL; Lyons T; McKinnon G; Hodgson SE; Abouchedid R; Gerostamoulos D; Koutsogiannis Z; Fitzgerald J; Greene SL;
Int J Drug Policy; 2023 Dec; 122():104251. PubMed ID: 37952318
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Drugs Network of Australia - Victoria Clinical Registry: A state-wide illicit substance surveillance and alert network.
Syrjanen R; Schumann J; Fitzgerald J; Gerostamoulos D; Abouchedid R; Rotella JA; Knott J; Maplesden J; Hollerer H; Hannon L; Bourke E; Hodgson SE; Greene SL
Emerg Med Australas; 2023 Feb; 35(1):82-88. PubMed ID: 36053993
[TBL] [Abstract][Full Text] [Related]
4. Non-fatal intoxications involving the novel benzodiazepine clonazolam: case series from the Emerging Drugs Network of Australia - Victoria project.
Syrjanen R; Greene SL; Castle JW; Di Rago M; Hodgson SE; Abouchedid R; Graudins A; Schumann JL
Clin Toxicol (Phila); 2023 Apr; 61(4):290-293. PubMed ID: 36988452
[TBL] [Abstract][Full Text] [Related]
5. Identification of clobromazolam in Australian emergency department intoxications using data-independent high-resolution mass spectrometry and the HighResNPS.com database.
Castle JW; Syrjanen R; Di Rago M; Schumann JL; Greene SL; Glowacki LL; Gerostamoulos D
J Anal Toxicol; 2024 Jun; 48(5):273-280. PubMed ID: 38459915
[TBL] [Abstract][Full Text] [Related]
6. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
[TBL] [Abstract][Full Text] [Related]
7. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
[TBL] [Abstract][Full Text] [Related]
8. From signal to alert: A cluster of exposures to counterfeit alprazolam tablets containing five novel benzodiazepines.
Syrjanen R; Schumann J; Hodgson SE; Abouchedid R; Rotella JA; Graudins A; Greene SL
Emerg Med Australas; 2023 Feb; 35(1):165-167. PubMed ID: 36271800
[TBL] [Abstract][Full Text] [Related]
9. Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project.
Beck O; Franzen L; Bäckberg M; Signell P; Helander A
Clin Toxicol (Phila); 2015 Nov; 53(9):865-73. PubMed ID: 26462932
[TBL] [Abstract][Full Text] [Related]
10. Co-exposure to gamma-hydroxybutyrate is associated with attenuated neuropsychiatric and stimulant effects of metamfetamine.
Greene SL; Syrjanen R; Hodgson SE; Abouchedid R; Schumann J
Clin Toxicol (Phila); 2024 May; 62(5):303-313. PubMed ID: 38884342
[TBL] [Abstract][Full Text] [Related]
11. Flualprazolam: Report of an Outbreak of a New Psychoactive Substance in Adolescents.
Blumenberg A; Hughes A; Reckers A; Ellison R; Gerona R
Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32581001
[TBL] [Abstract][Full Text] [Related]
12. Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project.
Helander A; Bäckberg M; Beck O
PLoS One; 2020; 15(4):e0232038. PubMed ID: 32324788
[TBL] [Abstract][Full Text] [Related]
13. The Emergence of New Psychoactive Substance (NPS) Benzodiazepines. A Survey of their Prevalence in Opioid Substitution Patients using LC-MS.
Mc Namara S; Stokes S; Nolan J
Ir Med J; 2019 Aug; 112(7):970. PubMed ID: 31642644
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: A 13-year retrospective study.
Niebel A; Westendorf L; Krumbiegel F; Hartwig S; Parr MK; Tsokos M
Drug Test Anal; 2022 Jan; 14(1):110-121. PubMed ID: 34435749
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.
Bäckberg M; Pettersson Bergstrand M; Beck O; Helander A
Clin Toxicol (Phila); 2019 Mar; 57(3):203-212. PubMed ID: 30348014
[TBL] [Abstract][Full Text] [Related]
16. Mortality related to novel psychoactive substances in Scotland, 2012: an exploratory study.
McAuley A; Hecht G; Barnsdale L; Thomson CS; Graham L; Priyadarshi S; Robertson JR
Int J Drug Policy; 2015 May; 26(5):461-7. PubMed ID: 25477285
[TBL] [Abstract][Full Text] [Related]
17. New psychoactive substances in Australia: patterns and characteristics of use, adverse effects, and interventions to reduce harm.
Sutherland R; Allsop S; Peacock A
Curr Opin Psychiatry; 2020 Jul; 33(4):343-351. PubMed ID: 32250983
[TBL] [Abstract][Full Text] [Related]
18. Establishing the protocols for the South Australian Emergency Department Admission Blood Psychoactive Testing (EDABPT) programme for drug surveillance.
Partridge E; Alfred S; Camilleri A; Green H; Haustead D; Kostakis C; Mallon J; Mason K; Rivers-Kennedy A; Stockham P
Emerg Med Australas; 2021 Oct; 33(5):883-887. PubMed ID: 33713558
[TBL] [Abstract][Full Text] [Related]
19. Typology of new psychoactive substance use among the general Australian population.
Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
[TBL] [Abstract][Full Text] [Related]
20. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
Heikman P; Sundström M; Pelander A; Ojanperä I
Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
